Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014
Authors
Keywords
-
Journal
International Journal of Environmental Research and Public Health
Volume 16, Issue 4, Pages 605
Publisher
MDPI AG
Online
2019-02-20
DOI
10.3390/ijerph16040605
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Calling time on asthma deaths in tropical regions—how much longer must people wait for essential medicines?
- (2018) Innes Asher et al. Lancet Respiratory Medicine
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Mohsen Naghavi et al. LANCET
- Essential medicines for universal health coverage
- (2017) Veronika J Wirtz et al. LANCET
- The case for an essential medicines list for Canada
- (2016) Gina Eom et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Access to essential medicines to treat chronic respiratory disease in low-income countries
- (2016) K. Bissell et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Essential medicines are still essential
- (2015) Andy L Gray et al. LANCET
- Medicines availability for non-communicable diseases: the case for standardized monitoring
- (2015) Jane Robertson et al. Globalization and Health
- Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries
- (2015) David Beran et al. Lancet Respiratory Medicine
- Essential Medicines in a High Income Country: Essential to Whom?
- (2015) Mai Duong et al. PLoS One
- The importance of measuring asthma control in emerging economies [Editorial]
- (2014) J. Mark FitzGerald et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration
- (2013) Hans V Hogerzeil et al. LANCET
- The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries
- (2013) Zaheer-Ud-Din Babar et al. PHARMACOECONOMICS
- Asthma in the global NCD agenda: a neglected epidemic
- (2013) Neil Pearce et al. Lancet Respiratory Medicine
- Access to medicines from a health system perspective
- (2012) M. Bigdeli et al. HEALTH POLICY AND PLANNING
- Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries
- (2011) Alexandra Cameron et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Access to essential medicines in national constitutions
- (2010) SK Perehudoff et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Impact of socioeconomic status on the use of inhaled corticosteroids in young adult asthmatics
- (2010) Jesper Rømhild Davidsen et al. RESPIRATORY MEDICINE
- Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC)
- (2009) C K W Lai et al. THORAX
- Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
- (2008) A Cameron et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started